Mutational Profiles Reveal an Aberrant TGF-β-CEA Regulated Pathway in Colon Adenomas
Open Access
- 21 April 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (4) , e0153933
Abstract
Mutational processes and signatures that drive early tumorigenesis are centrally important for early cancer prevention. Yet, to date, biomarkers and risk factors for polyps (adenomas) that inordinately and rapidly develop into colon cancer remain poorly defined. Here, we describe surprisingly high mutational profiles through whole-genome sequence (WGS) analysis in 2 of 4 pairs of benign colorectal adenoma tissue samples. Unsupervised hierarchical clustered transcriptomic analysis of a further 7 pairs of adenomas reveals distinct mutational signatures regardless of adenoma size. Transitional single nucleotide substitutions of C:G>T:A predominate in the adenoma mutational spectrum. Strikingly, we observe mutations in the TGF-β pathway and CEA-associated genes in 4 out of 11 adenomas, overlapping with the Wnt pathway. Immunohistochemical labeling reveals a nearly 5-fold increase in CEA levels in 23% of adenoma samples with a concomitant loss of TGF-β signaling. We also define a functional role by which the CEA B3 domain interacts with TGFBR1, potentially inactivating the tumor suppressor function of TGF-β signaling. Our study uncovers diverse mutational processes underlying the transition from early adenoma to cancer. This has broad implications for biomarker-driven targeting of CEA/TGF-β in high-risk adenomas and may lead to early detection of aggressive adenoma to CRC progression.Keywords
Funding Information
- US National Institutes of Health NCI (R01CA106614)
- National Institutes of Health (R01CA042857)
- National Institutes of Health (P01CA130821)
- National Institutes of Health (P30CA016672)
- National Institute on Alcohol Abuse and Alcoholism (R01AA023146)
This publication has 37 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- A colorectal cancer classification system that associates cellular phenotype and responses to therapyNature Medicine, 2013
- Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targetingBritish Journal of Cancer, 2013
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer SurvivalNew England Journal of Medicine, 2012
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer DeathsNew England Journal of Medicine, 2012
- Carcinoembryonic Antigen Interacts with TGF-β Receptor and Inhibits TGF-β Signaling in Colorectal CancersCancer Research, 2010
- The cancer genomeNature, 2009
- The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancerOncogene, 2005
- Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion moleculeCell, 1989